Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Pediatric Neurology · Developmental and/or Epileptic Encephalopathy with Spike-Wave Activation in Sleep

Treatment Options: Rescuing Your Child's Learning and Development

At a Glance

Treatment for D/EE-SWAS aims to do more than stop visible seizures: it reduces abnormal spike-wave activity during sleep so a child’s brain can better support learning, language, attention, and development. Steroids, benzodiazepines, and other medicines may be considered with EEG monitoring.

The goal of treatment for D/EE-SWAS is far more ambitious than for most other types of epilepsy. While typical epilepsy treatment focuses on stopping visible seizures, the goal here is cognitive rescue—reducing the “electrical noise” during sleep so that your child’s brain can regain its ability to learn and process information [1][2].

Common Medical Options

Most specialists consider two main paths for initial treatment. Because this condition involves a complex “network” problem between the thalamus and the cortex, standard anti-seizure medications (like levetiracetam or valproate) are often not powerful enough to clear the sleep EEG on their own [2][3].

  1. Corticosteroids (Steroids): These are frequently considered by specialists for “rebooting” the brain’s electrical activity [1].

    • The RESCUE-ESES Trial: This study compared steroids to clobazam (a benzodiazepine). It found that children on steroids were more likely to show a significant improvement in their IQ scores—about 25% of the steroid group reached the “responder” threshold, compared to 0% in the clobazam group [4]. Note that this trial was prematurely terminated, so these numbers should be viewed as guiding evidence rather than a universal guarantee.
    • How They are Given: Steroids may be given as a high-dose daily pill (prednisolone) or as “pulses” of high-dose IV medicine (methylprednisolone) once a month [4][5].
    • Side Effects: Weight gain is the most common concern, affecting nearly half of children. Mood changes, increased appetite, and a higher risk of infection are also closely monitored [4][6]. Steroids require clinician-directed monitoring for blood pressure, glucose, infection risk, mood, and adrenal suppression.
  2. High-Dose Benzodiazepines: Medications like clobazam or high-dose nocturnal diazepam are common alternatives.

    • How They Work: These are often given at bedtime to target the brain waves specifically as the child falls into sleep [7].
    • The “Waning” Effect: While benzodiazepines can be very effective initially, their impact sometimes fades over time as the body builds a tolerance. In one study, more than half of the children (10 out of 18) who initially responded to nocturnal diazepam saw the abnormal brain waves return (relapse) during follow-up [7].
    • Side Effects: Fatigue, drowsiness, and behavioral changes (like irritability) are the most frequent issues [4][8]. They can cause respiratory depression, tolerance, and withdrawal. Never start, stop, or rapidly taper these medications without your treating team’s plan.

The Danger of Relapse

Relapse—the return of the intense spike-wave activity—is a significant hurdle in D/EE-SWAS. It is not a sign that you or the doctors did anything wrong; it is simply the nature of this complex condition.

  • Relapse during Taper: It is common for the abnormal EEG patterns to return while a child is slowly lowering their dose of steroids or benzodiazepines [6].
  • Late Relapse: Even after a successful course of treatment, about 33% of children may experience a recurrence within six months of stopping the medication [9].
  • Monitoring is Key: Because of this risk, your child will need frequent follow-up EEGs to ensure the “electrical noise” stays away [7][6]. Monitoring intervals are individualized. Some children need more frequent checks.

Other Treatment Options

If the first options are not successful, your doctor may suggest other approaches:

  • Ethosuximide: Traditionally used for “staring” (absence) seizures, this can help reduce the spike-wave index in some children [10].
  • Sulthiame: This medication, used more frequently in Europe, has helped some children improve their school performance and reduce abnormal brain activity [11].

What to Watch For

Successful treatment is measured by two things: a “cleaner” EEG and a child who is more “present.” You are the best judge of the latter. While the doctors look at the Spike-Wave Index (SWI), you should be watching for:

  • Improvements in language and “word-finding.”
  • Better focus and attention at school.
  • A decrease in clumsiness or “foggy” behavior.

If the EEG improves but your child’s skills do not, it may mean the brain needs more time to “heal,” or that the treatment plan needs to be adjusted [12][13]. Tracking these small daily wins is as important as any medical test.

Common questions in this guide

What is the main goal of treatment for D/EE-SWAS?
The goal is not only to stop visible seizures. Treatment aims to reduce abnormal spike-wave activity during sleep so the child’s brain can better support learning, language, attention, and development.
Should my child receive steroids or benzodiazepines first for D/EE-SWAS?
Steroids and high-dose benzodiazepines such as clobazam or nocturnal diazepam are common initial options, but the best choice depends on the child’s EEG, development, health, and treating team. One trial found that more children met the study’s IQ-improvement threshold with steroids than with clobazam, but the trial ended early, so the result is not a guarantee for every child.
What side effects need monitoring during high-dose steroid treatment?
Weight gain is common, and children may also have increased appetite, mood changes, a higher risk of infection, and changes in blood pressure or blood glucose. The treating team may also monitor for adrenal suppression and should give the family a specific safety plan.
Can the abnormal EEG activity return after treatment?
Yes. Spike-wave activity may return during a gradual medication taper or later after treatment has ended; recurrence within six months can occur in some children. Follow-up EEGs and an individualized taper plan help the team detect and respond to relapse.
How will we know whether D/EE-SWAS treatment is helping?
Doctors look for a cleaner sleep EEG, while caregivers may notice better language and word-finding, improved attention, and less clumsiness or foggy behavior. EEG improvement and day-to-day skill improvement may not happen at the same speed, so both should be tracked.
What happens if the first D/EE-SWAS treatment does not work?
The treating team may adjust the plan or consider other medicines, including ethosuximide or sulthiame. The next step depends on the child’s EEG, symptoms, treatment response, and medication safety.

Get notified when new evidence is published on Continuous spikes and waves during sleep.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Developmental and/or Epileptic Encephalopathy with Spike-Wave Activation in Sleep: From Thalamocortical Mechanisms to Precision Therapy.

    Samanta D

    Children (Basel, Switzerland) 2026; (13(8)) doi:10.3390/children13080993.

    PMID: 42650333
  2. 2

    Thalamic epileptic spikes disrupt sleep spindles in patients with epileptic encephalopathy.

    Wodeyar A, Chinappen D, Mylonas D, et al.

    Brain : a journal of neurology 2024; (147(8)):2803-2816 doi:10.1093/brain/awae119.

    PMID: 38650060
  3. 3

    Electrical status epilepticus in sleep (ESES) - Treatment pattern and EEG outcome in children with very high spike-wave index.

    Wiwattanadittakul N, Depositario-Cabacar D, Zelleke TG

    Epilepsy & behavior : E&B 2020; (105()):106965 doi:10.1016/j.yebeh.2020.106965.

    PMID: 32155577
  4. 4

    Corticosteroids versus clobazam for treatment of children with epileptic encephalopathy with spike-wave activation in sleep (RESCUE ESES): a multicentre randomised controlled trial.

    van Arnhem MML, van den Munckhof B, Arzimanoglou A, et al.

    The Lancet. Neurology 2024; (23(2)):147-156 doi:10.1016/S1474-4422(23)00409-X.

    PMID: 38081201
  5. 5

    European experience of steroid therapy in children with developmental and epileptic encephalopathy with spike wave activation in sleep ((D)EE-SWAS).

    Canbay D, Jansen FE, Schönberger J, et al.

    Orphanet journal of rare diseases 2025; (20(1)):204 doi:10.1186/s13023-025-03725-0.

    PMID: 40301922
  6. 6

    A prospective study of dexamethasone therapy in refractory epileptic encephalopathy with continuous spike-and-wave during sleep.

    Chen J, Cai F, Jiang L, et al.

    Epilepsy & behavior : E&B 2016; (55()):1-5.

    PMID: 26720702
  7. 7

    EEG response to high dose nocturnal diazepam in children with developmental/epileptic encephalopathy with spike-and-wave activation in sleep (DEE/EE-SWAS).

    Kiani H, Whitney R, Go C, et al.

    Epilepsy & behavior : E&B 2025; (171()):110498 doi:10.1016/j.yebeh.2025.110498.

    PMID: 40412341
  8. 8

    High-dose diazepam as a long-term treatment strategy for epileptic encephalopathy and developmental epileptic encephalopathy spike-and-wave activation in sleep: A tertiary center's experience.

    Hamed N, Dayan EZ, Heimer G, et al.

    Epilepsy & behavior : E&B 2025; (171()):110482 doi:10.1016/j.yebeh.2025.110482.

    PMID: 40403488
  9. 9

    Exploratory analysis of high-dose corticosteroid therapy on epileptic encephalopathy with spike-and-wave activation in sleep.

    Xiaoyue H, Hongwei T, Jianbiao W, et al.

    Frontiers in pediatrics 2024; (12()):1388008 doi:10.3389/fped.2024.1388008.

    PMID: 39184857
  10. 10

    Electroclinical and behavioral outcomes of add-on ethosuximide in children with developmental and epileptic encephalopathy with spike-wave activation in sleep (D/EE-SWAS): A prospective observational study.

    Sahu A, Saini AG, Sharma R, et al.

    Seizure 2026; (141()):125-132 doi:10.1016/j.seizure.2026.07.008.

    PMID: 42485909
  11. 11

    Effects of sulthiame on seizure frequency and EEG in children with electrical status epilepticus during slow sleep.

    Topçu Y, Kılıç B, Tekin HG, et al.

    Epilepsy & behavior : E&B 2021; (116()):107793 doi:10.1016/j.yebeh.2021.107793.

    PMID: 33549940
  12. 12

    Intelligence outcomes in 17 patients with developmental and/or epileptic encephalopathy with spike-wave activation in sleep ((D)EE-SWAS) after remission of SWAS.

    van Arnhem MML, van Teeseling HC, van den Berg L, et al.

    Epilepsy & behavior : E&B 2025; (173()):110806 doi:10.1016/j.yebeh.2025.110806.

    PMID: 41192048
  13. 13

    Treatment of electrical status epilepticus in sleep: Clinical and EEG characteristics and response to 147 treatments in 47 patients.

    van den Munckhof B, Alderweireld C, Davelaar S, et al.

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2018; (22(1)):64-71 doi:10.1016/j.ejpn.2017.08.006.

    PMID: 29128194

This page is for caregivers learning about D/EE-SWAS treatment and does not replace medical advice. A pediatric neurologist or epilepsy specialist should guide medication choices, monitoring, tapering, and relapse care for your child.